Bulletin
Investor Alert

London Markets Open in:

Topics

New York Times

/marketstate/country/us

After Hours

12/03/21

NYT
New York Times Co. Cl A
/zigman2/quotes/202090840/composite

$

47.00

Change

-0.47 -0.99%

Volume

Volume 8,711

Quotes are delayed by 20 min

/zigman2/quotes/202090840/composite

Previous close

$ 47.02

$ 47.47

Change

+0.45 +0.96%

Day low

Day high

$46.89

$47.72

Open

52 week low

52 week high

$39.73

$58.73

Open
1:25 a.m. Nov. 19, 2021 - By Tomi Kilgore
Coronavirus tally: Daily average of new COVID-19 cases rises to 6-week high, daily death toll holds above 1,000The global tally for the coronavirus-borne illness rose to a total of 256.2 million on Friday, while the death toll climbed to 5.14 million, according to . The U.S. leads the world with a total COVID-19 case count of 47.5 million and death toll of 768,697. The daily case count topped 100,000 for a second straight day on Thursday, with the seven-day average rising to a six-week high of 94,669, according to . The average daily death count remained above 1,000 for the past three months, rising to 1,158 on Thursday from 1,088 on Wednesday. The daily average of hospitalizations remained flat at 48,276. Michigan led the U.S. in average daily cases with 8,398, followed by New York at 5,986. A decision on is expected by Friday, according to media reports. The FDA is expected to make an announcement that will be followed on Friday by a meeting of a CDC advisory committee on the topic.
2:14 a.m. Aug. 25, 2021 - By Tomi Kilgore
Coronavirus tally: Daily average of COVID-19 cases rises to 7-month high, as J&J data supports booster shotsThe global tally for the coronavirus-borne illness climbed to 213.30 million as of early Wednesday, while the death toll rose to 4,454,812, according to . The U.S. led the world with a total of 38.08 million cases and 630,838 deaths. The daily average of new cases over the past seven days rose to 151,441 as of Tuesday, up 28% from two weeks ago, and the highest count since Jan. 29, according to . The daily average for deaths increased to 1,116, up 84% in two weeks and the most since March 19. The daily average for hospitalizations of rose to 94,082, up 35% from two weeks ago and the most since Feb. 6. The number of people that have been fully vaccinated grew to 171.4 million, or 51.6% of the total U.S. population, according to , while the number of people who have received at least one dose of a vaccine edged up to 202.04 million, or 60.9% of the total population. Johnson & Johnson announced Wednesday data that supported the use of a COVID-19 vaccine booster shot, eight months after people previously received J&J's single-shot vaccine.
1:22 a.m. Aug. 24, 2021 - By Tomi Kilgore
Coronavirus tally: Daily average for new cases, deaths and hospitalizations keep climbing to multi-month highsThe global tally for the coronavirus-borne illness climbed to above 212.61 million as of early Tuesday, while death toll rose to 4,442,545, according to . The U.S. led the world with a total of 37.94 million cases and 629,411 deaths. The daily average of new cases over the past seven days rose to 150,625 as of Monday, up 29% from two weeks ago, and the highest count since Jan. 30, according to . The daily average for deaths increased to 1,057, up 91 in two weeks and the most since March 24. The daily average for hospitalizations of 93,318 was up 39% from two weeks ago and the most since Feb. 6. The number of people that have been fully vaccinated rose to 171.1 million, or 51.5% of the total U.S. population, according to , while the number of people who have received at least one dose of a vaccine edged up to 201.7 million, or 60.8% of the total population. Hopes that vaccination rates would increase were boosted by the Food and Drug Administration's developed by Pfizer Inc. and BioNTech SE on Monday for people at least 16 years old.
1:51 a.m. Aug. 23, 2021 - By Tomi Kilgore
Coronavirus tally: Average daily U.S. death toll tops 1,000 for first time in 5 months, FDA set to approve Pfizer vaccineThe global tally for the coronavirus-borne illness climbed to 211.9 million as of early Monday, while death toll rose to 4,432,694, according to . The U.S. led the world with a total of 37.71 million cases and 628,503 deaths. The daily average of new cases over the past seven days rose to 149,675 as of Sunday, up 36% from two weeks ago, but down from 150,138 on Saturday, according to . The daily average for deaths increased to 1,008, topping the 1,000 mark for a second-straight day, and up 95% in two weeks, and the most since March 25. Hospitalizations of 92,482 was up 43% from two weeks ago and the most since Feb. 6. The number of people that have been fully vaccinated rose to 170.82 million, or 51.5% of the total U.S. population, according to . The Food and Drug Administration is Pfizer Inc.'s and partner BioNTech SE's COVID-19 vaccine as early as Monday.
1:54 p.m. Aug. 20, 2021 - By Wallace Witkowski
Pfizer and BioNTech shares rise on report FDA could fully approve COVID-19 vaccine next weekPfizer Inc. and U.S.-listed shares of BioNTech SE rose in the extended session Friday following a report that the drug makers will likely get full Food and Drug Administration approval for their COVID-19 vaccine sometime next week. Pfizer shares rose more than 2% after hours, following a 0.2% decline to close at $48.72, and German-based BioNTech's ADRs rallied more than 5%, following a 5.1% gain to close at $348.68. Late Friday, that the FDA could approve the vaccine, which up until now has been distributed on an emergency basis, as early as Monday but could possibly go past that if regulators need more time to review data. The Department of Health and Human Services recently announced that to those who already received their first two shots. Back in July, Pfizer and BioNTech reported targeting the delta variant of the virus.
1:45 a.m. Aug. 20, 2021 - By Tomi Kilgore
Coronavirus tally: U.S. daily average of COVID-19 cases, deaths and hospitalization rise to multi-month highsThe global tally for the coronavirus-borne illness climbed above 210 million as of early Friday, while death toll rose to 4,404,511, according to . The U.S. led the world with a total of 37.29 million cases and 625,166 deaths. The daily average of new cases over the past seven days rose to 143,827 as of Thursday, up 44% from two weeks ago and the most since Feb. 1, according to . The daily average for deaths increased to 911, up 108% in two weeks, and the most since March 31, while hospitalizations of 86,877 was up 53% from two weeks ago and the most since Feb. 9. The number of people that have been fully vaccinated rose to 169.59 million, or 51.1% of the total U.S. population, according to . AstraZeneca PLC said Friday that in a late stage trial. "There were no cases of severe Covid-19 or Covid-19-related deaths in those treated with AZD7442," the company said.
1:55 a.m. Aug. 18, 2021 - By Tomi Kilgore
Coronavirus tally: Daily average of new cases slips, to snap a 39-day streak of increases based on NYT dataThe global tally for the coronavirus-borne illness climbed above 208.6 million as of early Wednesday, while death toll rose to 4,383,333, according to . The U.S. remained the world leader with 37.02 million cases and 623,322 deaths. On a daily basis, the seven-day average for cases slipped to 139,872 on Tuesday from 142,414 on Monday, to snap a 39-day streak of increases. The daily average was still up 52% from two weeks ago, and 4.5 times the average of 31,138 a month ago, . The daily average of deaths slipped to 696 on Tuesday from 704 on Monday, while hospitalizations increased to 83,291 from 82,519 on Monday, the most since Feb. 11. The number of people that have been fully vaccinated rose to 168.90 million, or 50.9% of the total U.S. population, according to . The U.S. is expected to announce Wednesday that most vaccinated Americans eight months after being fully vaccinated.
1:27 a.m. Aug. 17, 2021 - By Tomi Kilgore
Coronavirus tally: Global cases of COVID-19 nears 208 million, as U.S. reportedly set to recommend boostersThe global tally for the coronavirus-borne illness climbed above 207.9 million as of early Tuesday, while death toll rose to 4,372,554, according to . In the U.S., cases reached 36.89 million while deaths increased to 622,322, with both leading the world. On a daily basis, the seven-day average for cases grew to 141,365 on Monday, more than four times the daily average of 30,901 a month ago, and the most since Feb. 2, according to . The seven-day average for deaths rose to 704, up from 273 a month ago and the most since May 4, while hospitalizations rose to 81,556, up from 23,432 a month ago and the most since Feb. 12. The number of people that have been fully vaccinated rose to 168.69 million, or 50.8% of the total U.S. population, according to . The U.S. is set to announce that most vaccinated Americans shot eight months after being fully vaccinated, according to late Monday.
6:20 a.m. June 11, 2021 - By Tomi Kilgore
J&J stock drops after report FDA said millions of COVID-19 vaccine doses need to be discardedShares of Johnson & Johnson took a 1.4% hit in morning trading Friday, after a report that health officials decided the drugmaker needs to throw out millions of doses of its COVID-19 vaccine because of possible contamination. The New York Times reported Friday, citing people familiar with the situation, that after weeks of review, the Food and Drug Administration told J&J to discard 60 million doses of its vaccine made at a Baltimore plant under federal review, which is operated by Emergent BioSolutions Inc. , because of possible contamination. The FDA said Friday that it was authorizing emergency use of two batches of vaccines made at the Baltimore facility, even though it said it is "not yet ready" to include the plant as an authorized facility for the vaccine. The NYT report comes after the , to 4 1/2 months from 3 months, as supply piled up. J&J's stock has gained 3.6% over the past three months, while the SPDR Health Care Select Sector ETF has gained 8.6% and the Dow Jones Industrial Average has tacked on 5.9%.
3:36 a.m. April 1, 2021 - By Jaimy Lee
Emergent's stock falls 6.8% after error making J&J's COVID-19 vaccineShares of Emergent BioSolutions Inc. were down 6.8% in premarket trading on Thursday, the day after Johnson & Johnson that a batch of its COVID-19 vaccines manufactured at an Emergent plant did not meet "quality standards." The New York Times on Wednesday that 15 million doses of J&J's vaccine had been ruined as the result of a production mistake at an Emergent facility. Emergent is the U.S. manufacturing partner to J&J; that deal, worth $135 million, was announced in April of last year. J&J said Wednesday in a statement that the "quality control process identified one batch of drug substance that did not meet quality standards at Emergent BioSolutions, a site not yet authorized to manufacture drug substance for our COVID-19 vaccine." Emergent's stock has gained 71.0% over the past year, while the broader S&P 500 is up 53.7%.
1:28 a.m. March 16, 2021 - By Tomi Kilgore
Coronavirus tally: U.S. daily case and death tally edges up, but average for the week falls 18%The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed to 120,273,942 on Tuesday, according to , with the U.S. accounting for nearly one-quarter of the cases with 29,495,422. The global death toll grew to 2,662,067, while the U.S. death count rose to 535,628, or one-fifth of the worldwide total. On Monday, new cases increased to at least 57,081 from 38,034 on Sunday, and deaths rose to at least 751 people from 572 the day before, . The daily average of new cases over the past week was 55,153, down 18% from the average two weeks earlier. On the vaccine front, the show that 135,847,835 vaccine doses have been delivered, while 109,081,860 arms have been jabbed, including 71,054,445 people who have received at least one dose and 38,335,432 people who have been fully vaccinated. Outside of the U.S., Brazil has the second highest death toll at 279,286 and is second by cases at 11,519,609. India is third worldwide in cases with 11,409,831 million and fourth in deaths at 158,856. Mexico has the third highest death toll at 194,944 and 13th highest case tally at 2,167,729. The U.K. has the fifth-most cases at 4,276,840, while the death toll of 125,817 is fifth highest in the world and the highest in Europe.
3:47 a.m. March 10, 2021 - By Victor Reklaitis
Biden to unveil plans to obtain additional 100 million doses of J&J vaccine: reportPresident Joe Biden on Wednesday afternoon will announce plans to secure an additional 100 million doses of Johnson & Johnson's COVID-19 vaccine by year's end, according to a citing unnamed administration officials. The goal of the move is to have enough on hand to vaccinate children and, if necessary, administer booster doses or reformulate the vaccine to combat emerging variants, the report added. The announcement is expected at an event with the CEOs of J&J and Merck .
12:41 a.m. Jan. 13, 2021 - By Steve Goldstein
Johnson & Johnson vaccine production is behind schedule: reportFederal officials have been told that Johnson & Johnson's vaccine production has fallen as much as two months behind the original production schedule and won't catch up until the end of April, , citing people familiar with the situations. The report quoted the lead manufacturing adviser for Operation Warp Speed that the company might be able to catch up with initial production goals by March. Johnson & Johnson may release results from its COVID-19 vaccine, which is unique in that it only requires a single dose, in as little as two weeks, the report adds.
1:43 a.m. Dec. 23, 2020 - By Tomi Kilgore
Coronavirus tally: Daily death toll spikes back above 3,000 as hospitalizations jumps to another recordIt was a bad day on the COVID-19 front. While the number of daily new cases slipped to 201,674 on Tuesday from 201,723 on Monday, the number of deaths spiked up to 3,239 on Tuesday, the third-highest daily total ever, from 1,962 on Monday, according to . Hospitalizations jumped by 2,426 patients to a record 117,777 on Tuesday, . Overall, the U.S. has had 18,237,190 COVID-19 cases as of Wednesday morning and 322,849 deaths, according to . Globally, cases rose to 78,105,462 and deaths grew to 1,719,278. The grim numbers comes as the U.S. government is closing in on a deal to acquire tens of millions of additional doses of the COVID-19 vaccine from Pfizer Inc. and BioNTech SE , .
7:57 a.m. Dec. 14, 2020 - By Nicole Lyn Pesce
WATCH: Relieved Americans applaud as the Pfizer-BioNTech COVID-19 vaccine rolls out across the country Queens, N.Y., nurse Sandra Lindsay received the first COVID-19 vaccine in the U.S. on Monday morning Queens, N.Y., nurse Sandra Lindsay received the first COVID-19 vaccine in the U.S. on Monday morning
9:22 a.m. Dec. 10, 2020 - By Ciara Linnane
U.S. sets record one-day death toll from coronavirus as FDA committee meets to review Pfizer–BioNTech vaccine FDA head says initial assessment is ‘this is a vaccine that does meet our criteria. ... But we do want to hear from the vaccine advisory committee.’The U.S. set fresh records for single-day fatalities from the coronavirus illness COVID-19 and hospitalizations, as a U.S. regulatory advisory committee gathered to offer its verdict on the vaccine developed by Pfizer Inc. and its German partner BioNTech SE.
3:36 p.m. Dec. 8, 2020 - By Ciara Linnane
U.S. suffers deadliest week from coronavirus since pandemic broke out A group of doctors and scientists urge leaders to follow the science and stop the misinformation that has undermined the U.S. response to the crisisThe U.S. has set another grim milestone in the coronavirus pandemic, averaging the most deaths from COVID-19 in a week since the start of the outbreak, as cases continue to rise across the country and hospitals fill with patients
Browse topics:

Filter results by

Location

Us (261)

Asia Pacific (20)

Europe (20)

Eu (13)

Latin America (12)

South America (5)

Link to MarketWatch's Slice.